[1]
Silverberg, J., Bieber, T., Paller, A., Beck, L., Kamata, M., Puig, L., Wiseman, M., Ezzedine, K., Foley, P., Johansson, E., Dossenbach, M., Akmaz, B., Casillas, M., Karlsson, A. and Chovatiya, R. 2024. Efficacy Comparison of Targeted Systemic Monotherapies Including Lebrikizumab for Moderate-to-Severe Atopic Dermatitis: a Network Meta-Analysis. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s313. DOI:https://doi.org/10.25251/skin.8.supp.313.